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Next generation sequencing technologies are bringing about a renaissance of mining
approaches. A comprehensive picture of the genetic landscape of an individual patient
will be useful, for example, to identify groups of patients that do or do not respond to
certain therapies. The high expectations may however not be satisfied if the number of
patient groups with similar characteristics is going to be very large. I therefore doubt that
mining sequence data will give us an understanding of why and when therapies work.
For understanding the mechanisms underlying diseases, an alternative approach is to
model small networks in quantitative mechanistic detail, to elucidate the role of gene
and proteins in dynamically changing the functioning of cells. Here an obvious critique is
that these models consider too few components, compared to what might be relevant for
any particular cell function. I show here that mining approaches and dynamical systems
theory are two ends of a spectrum of methodologies to choose from. Drawing upon
personal experience in numerous interdisciplinary collaborations, I provide guidance on
how to model by discussing the question “Why model?”
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WHY SYSTEMS BIOLOGY?
I accepted 10 years ago what was then the first professorship ded-
icated to “systems biology” in Europe. These 10 years have given
me sufficient time to reflect upon the role of mathematical mod-
eling for the study of cellular systems. One particular experience,
which I want to share here, is the first encounter of “modelers”,
like myself and “experimentalists” in meetings that were set up
to discuss the possibility for an interdisciplinary collaboration
between our groups.
On such occasions, the question “What is Systems Biology?”
is occasionally discussed, although I find the question “Why
model?” more important. I shall thus focus on the arguments
for mathematical modeling of cellular systems, beginning with
my favorite definition of systems biology: Systems biology is the
science that studies how biological function emerges from the
interactions between the components of living systems and how
these emergent properties enable and constrain the behavior of
those components1. This definition does not only integrate many
different views but also highlights the fact that systems biology
is not a separate discipline but part of biology and biomedicine.
Systems biology is thus an approach to understanding com-
plex, i.e., non-linear spatio-temporal phenomena, across multiple
levels of structural and functional organization. And for most
projects I have been involved in, this approach is characterized
by a combination of experiments with mathematical, statistical,
and computational modeling.
From first encounters between my group and colleagues in the
biological or biomedical sciences, I learned that even the most
enthusiastic experimentalist would harbor the question “Why
1I heard this definition for the first time from Jan-Hendrik Hofmeyr
(University of Stellenbosch).
model?” or “What is it doing for me?” in his/her mind. These are
fair questions and I don’t find it is easy to answer them in the short
time that is typically available in such meetings.
A quick answer is that, for complex systems, all alternatives
for understanding the system involve creating a model of some
sort. We cannot understand complex systems without modeling.
For example, even a diagram that identifies the components of a
system (e.g., a network or pathway) and has arrows to indicate
interactions between them is a conceptual model. For complex
systems, new understanding about how the system might work
is generated by transforming one reality into another. This latter,
reduced or abstracted form may be a diagram, a physical model
or a mathematical model. Many projects in systems biology
translate diagrammatic representations into mathematical mod-
els. Through simulation, such models help understanding if the
original interactions diagram appropriately captured molecular
components and interactions related to cell functions (e.g., apop-
tosis or cell differentiation). The iterative cycle of data-driven
modeling and model-driven experimentation, in which alterna-
tive hypotheses are postulated and refined until they are validated,
helps in identifying newmechanistic details of cell-biological pro-
cesses and previously unidentified regulatory interactions in the
system.
Even though I suggested above that modeling is ubiquitous,
the complexity of biological systems and current experimen-
tal technological bottlenecks may limit the modeling that can
be undertaken in the course of many wet-lab centered research
projects. When experimental bottlenecks prevent generating the
appropriate data to create a mathematical model that could
answer the questions asked in the project, I would empha-
size that the modeling process itself requires a way of think-
ing that can be beneficial to the design of experiments. In the
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next section, I shall provide some examples to clarify what I
mean and convince the skeptical reader of the points made
above.
EXAMPLES FOR THE SYSTEMS BIOLOGY APPROACH
Earlier, I described meetings in which experimentalists and mod-
elers come together with an interest to collaborate but I have also
been in meetings where the value of a systems biology approach
and the role of mathematical modeling were questioned. This
often leads to a question about “success stories” in systems biol-
ogy. In response, many people would refer to the virtual heart
effort, with Denis Noble as one of its pioneers (Noble, 2008).
While the virtual heart project is a truly fantastic example, it is
also a long-term effort, involving a large number of researchers.
Therefore, this example will not help me convince naysayers in
meetings where I sit together with a few colleagues from another
faculty across the campus and where we try to identify possibil-
ities for collaborations that may lead to fundable projects in the
3-year projects model that most funding agencies currently use.
I shall give here a small selection of examples that I found use-
ful in explaining my colleagues and potential collaborators how
modeling can contribute to their work.
The first type of project I like to use as an example, inves-
tigates the temporal evolution of cell populations in response
to some perturbation. Data from FACS measurements provide
information about phenotypic states and a stochastic model
allows predicting whether and how subpopulations of cells reach
equilibrium proportions over time. These predictions about the
expected heterogeneity in the proportions of different tumor
cell types over time can be used to design drug-dosing sched-
ules for chemotherapy in cancer research (e.g., Foo and Michor,
2009; Liao et al., 2012). Stochastic models are ideally suited for
situations where biological variability as well as uncertainty in
measurements may significantly affect the interpretation of data.
Unfortunately, the seemingly more abstract notation for stochas-
tic modeling prevents some people from using it. This motivated
us to write a textbook on stochastic modeling for systems biology
(Ullah and Wolkenhauer, 2011).
The second type of project frequently starts by creating a
computerized version of an interaction map that gathers all infor-
mation about molecular components and interactions that may
be relevant to a process under consideration. These maps help
us to organize disparate information into a coherent whole.
One can then explore the full map and roughly analyze the
types of dynamic behavior that it may generate, either by using
graph theory or by interpreting interactions as logical relations.
Alternatively, one can use the map as the basis for the selection
of a subnetwork, which is subsequently investigated with a more
detailed kinetic/mechanistic model. For example, based on such
a regulatory map of p21, which includes its transcriptional fac-
tors, targeting miRNAs and interacting proteins we constructed a
kinetic model to describe the repression of the target hub gene
p21 by multiple miRNAs. The model was calibrated and vali-
dated with northern and western blot data and was subsequently
used to predict the effect of different miRNAs expression profiles
in combination with their cooperativity on determining the p21
expression levels for different biological contexts (Lai et al., 2012).
The third type of project can be viewed as a mix of the first
two types and involves the use of multi-scale models. These allow
us to study interactions between molecules, cells, and their envi-
ronment at different scales, in time and space. For example in
breast cancer, spatio-temporal models have provided new insights
into the progression of the disease by showing how the tumor
and stroma interact (e.g., Basanta et al., 2009). The models were
used to generate hypothesis about key molecular/cellular inter-
actions that result in a specific formation of cancer cells in their
environment. Subsequent microscopy and Western blot experi-
ments confirmed the hypotheses. Multi-scale model often employ
agent-based simulations, which are well suited to describe spatio-
temporal processes. The behavior of individual “agents” (e.g.,
cells) can be formulated in terms of a few relatively simple rules,
with complex behavior emerging from the interactions among the
agents. The two difficulties we have with this approach is that the
models are encoded in large amounts of programming code that
is often difficult to check and the simulations can also require
considerable computational resources. There is thus scope for
further improvements of our tools and interesting opportunities
for research into the mathematical and computational tools. In
another cancer research project, focusing on tumor-stroma inter-
actions, we used this approach to simulate of molecular diffusion
in environments with impenetrable barriers. This taught us that
modeling requires a careful balance between the simplicity of a
model (helping its implementation and efficient simulation) and
the required level of detail that makes the model predictive for the
application.
Independently of the type of project we undertake, modeling
is never its own final goal. It is a tool we use to increase under-
standing of the biological system and to develop more directed
experiments. For example, in one of our longer running collabo-
rations with Robert Jaster, we established a rate equation model
describing IFNg induced STAT1 signaling in pancreatic stellate
cells. The model was calibrated with experimental time series for
STAT1 activation and SOCS1 mRNA expression. Once the model
is established, simulations can be used to predict the response of
the system to different patterns of stimulation. This allowed us
to predict the temporal responses of STAT1 and SOCS1 after a
dose split stimulation of the cells with IFNg. These predictions
were experimentally validated, reinforcing our confidence that the
model was a good starting point for the design of new exper-
iments and emphasizing that the mechanisms described in the
model can account for the experimentally observed phenomena
(Rateitschak et al., 2010). Such mechanistic modeling of sig-
naling networks can also be used to study differences between
cell types. For example, in one of our experiments the time
course profiles for phosphorylation and nuclear accumulation of
a pathway response showed variations between two cell types.
We established a rate equation model and calibrated it with
experimental data from both cell types. By using simulations to
investigate the variability in the dynamic behavior of the model
as a consequence of the uncertainty in the estimated param-
eter values, we could identify reactions that differ in the two
cell types. This provided the basis for a prediction of therapeu-
tic targets that are valid for both cell types (Rateitschak et al.,
2012).
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Virtually all of the projects in which we have used models, are
focused on a particular experimental context, including a cho-
sen experimental model and often linked to specific technologies
used to generate data. Each of these projects produces a piece of
evidence for or against some hypothesis that is usually addressing
a far more general question. For example, many projects that seek
a better understanding of apoptosis, will conduct experiments for
a relatively small number of relevant components. The results
provided by these experiments will then have to be complemented
with evidence from other studies to make a plausible argument in
the more general context of apoptosis. Review articles in leading
journals play an important role in putting the pieces of such puz-
zles together, helping us to fit a relatively small experiment into a
larger picture. This process of “theorizing” in which we integrate
and generalize evidence is something I believe should also be sup-
ported with mathematical modeling (Wolkenhauer and Green,
2013).
At this stage I hope that the reader is already convinced about
the importance of the systems biology approach and usefulness
of mathematical modeling to experimental biologists. The good
news is that even simple models can often be useful; a detailed
model of either a virtual brain or a virtual human is by no means
required to have a productive collaboration with an experimen-
tal or clinical researcher. One of the most important lessons I
learned from working with experimentalists is that the construc-
tion of a model promotes a “way of thinking” that critically
assesses relevant system variables and their interactions. The pro-
cess of constructing a model is thus as valuable as the model
itself and “modeling as a way of thinking” has a lot more to offer
than numerical “predictions”. Mathematical modeling helps us to
explain relationships between parts of a system, to illuminate the
core dynamics of processes, to bound biological outcomes within
plausible ranges, and to illuminate uncertainties (Epstein, 2008).
In systems biology, the role of the model is to make something
complex intelligible or understandable. To make this contribu-
tion, the model should be as simple as possible and as detailed as
necessary. In other words, a model should abstract (and thereby
reduce) a complex reality into a relatively simple structure. It is
through this transformation of one reality into another that we
gain understanding. This process however requires us to make
assumptions and thus modeling is the art of making reasonable
assumptions and appropriate choices.
NAVIGATING THROUGH THE ZOO OF MODELING
APPROACHES
The examples of models described above included stochastic
models (specifically Markov processes), rate equation models
(ordinary differential equations) and multi-scale models (agent-
based simulations). There are many other examples one could
give, but instead I will try to summarize what type of frequently
used models exist and how they can be used. I do this with the
intention of motivating the modeler who reads this essay to for-
mulate his own examples of success stories and to further detail
how modeling can be a useful complementary effort for exper-
imental biologists. Figure 1 provides a tabular summary of key
questions in biology and illustrates how these can be addressed
through mathematical modeling.
There is a whole zoo of modeling approaches to choose from,
and which approach is chosen will largely depend upon the type
of question asked and on the data available. The vast majority of
questions in the life sciences are simply asking about the effect
that “differences” have in the biology (e.g., response of patients
with or without treatment, phenotypes of wild type vs. mutant,
physiological behavior before and after a perturbation). On a
very basic level, statistical models in significance testing allow us
to determine the significance of, and the uncertainty in, exper-
imentally observed differences. If one is however interested in
how changing the levels of a system variable changes the levels
of another system variable, this will take us up a notch on the
scale of model complexity and move us to correlation analyses.
If explicit formulaic relationships between variables are required,
then regression models will be an appropriate choice.
However, to address the questions posed in many projects, sta-
tistical models are either not sufficient or only the first step toward
explanatory models. For if we wish to “explain” the mechanisms
underlying some observed phenomenon, mechanistic models are
used to analyze interaction networks. The starting point for
mechanistic models is usually a network diagram that depicts the
components of the system, and uses arrows to indicate the type of
interactions that exist between components. For most cases, these
interaction maps will involve feedback or feedforward mecha-
nisms, where changes in one variable y, will influence another
variable x, in a way that involve neither direct signaling nor mat-
ter conversion between the two. Such regulatory mechanisms can
generate non-linear dynamical phenomena, producing counter-
intuitive observations. If the evidence for the interactions is not
strong and the data about the system’s behavior is mostly quali-
tative, one is safer using a logical representation to create models
for the analysis of systemic behavior (e.g., a gene being on or off,
distinguishing only activation and deactivation etc.). Using this
approach one can construct and analyze large networks, if one is
able to live with results that are not quantitative. Logical mod-
els are often taken as a formal representation and integration of
existing knowledge from the literature and are then used to find
hints for which system variables may be most important, possi-
bly preparing a more detailed model of a subset of the overall
network.
If the relevant components in a network are largely known,
one can, for smaller systems, develop detailed parametric mod-
els that, when calibrated with experimental data, allow in sil-
ico experiments to predict the dynamical behavior of the sys-
tem following perturbations. In this context, sensitivity analy-
sis is an important tool to investigate the system’s behavior in
response to changes in the system. Such focused mechanistic
models represent interactions among system variables in terms
of biochemical or biophysical properties (say a rate equation
model).
FROM SYSTEMS BIOLOGY TO SYSTEMS MEDICINE
As research institutions and funding bodies prepare for Systems
Medicine, there will be many more meetings in which clinicians
and biomedical researchers meet colleagues from engineering,
mathematics and computer science in order to discuss the poten-
tial for interdisciplinary collaborations. While the use of IT and
www.frontiersin.org January 2014 | Volume 5 | Article 21 | 3
Wolkenhauer Why model?
FIGURE 1 | Answering biological questions through mathematical
analyses. The table illustrates a selection of approaches available in
systems biology. In practice, the vast majority of questions in
experimental biology concern “differences.” Given that experimental
observations vary, statistical testing will establish the significance of a
difference. The experiments for this type of question are easy to conduct
but little more than establishing a difference is possible. At the other end
of the spectrum models of dynamical systems allow investigations about
causal mechanisms underlying complex interaction networks. These very
powerful explanatory models do however require sufficiently rich
quantitative time course experiments, which in many cases are
time-consuming, expensive and technically more challenging.
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bioinformatics approaches is perceived as an obvious and valu-
able addition to projects in a clinical setting, my experience is that
mathematical modeling will require more effort to convince your
colleagues. At the core of the discussion is the value ofmethodolo-
gies, compared to the enthusiasm about new technologies (Green
and Wolkenhauer, 2012; Wolkenhauer et al., 2013).
There is no doubt that advances in the life sciences have
been largely driven by new technologies. For example, with next
generation sequencing techniques, one notices that the old bioin-
formatics “mining philosophy” has regained strength. Detecting
patterns in the genetic landscape of samples from individual
patients will provide useful information, for example, to refine the
classification of groups. The data analysis is comparatively easy
and leads to the creation of ever smaller shoe-boxes in which to
put cases. This approach will however not take us very far and
at some point the need to “understand” the reasons behind these
pattern and patient groups will resurface.
Returning to the setting I described above, in a first encounter
with experimentally working biologists, what does a collaboration
with a modeler imply? I suppose, in most cases, the honest answer
is “more work”. This is true whether the experimentalist uses a
statistical model to explain data, requiring replicates to quantify
uncertainty, or a mechanistic model, requiring sufficiently rich
quantitative time courses. In general, the more interesting the
question being asked is, the greater the effort in generating the
data will be. Statistical models, used to detect simple differences
between samples, may be enough to support basic hypotheses
about the involvement of a molecular component in a process.
However, if we are to understand the mechanisms underlying
cell and tissue function, there is no escape from the theory of
dynamical systems, with costly and time consuming experiments
to generate suitable datasets. I am however utterly convinced that
the effort will be worth it because it will lead to new ways of think-
ing about biological complexity and it will immensely increase
our understanding about how living organisms function. Such
goals cannot be achieved without mathematical modeling.
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